Inotropes and cardiorenal syndrome in acute heart failure – A retrospective comparative analysis

Nieminen, 2006, EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population, Eur Heart J, 27, 2725, 10.1093/eurheartj/ehl193 Mebazaa, 2015, Eur J Heart Fail, 17, 544, 10.1002/ejhf.289 Yilmaz, 2013, Renal effects of levosimendan: a consensus report, Cardiovasc Drugs Ther, 27, 581, 10.1007/s10557-013-6485-6 Heywood, 2007, High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report From the ADHERE database, J Card Fail, 13, 422, 10.1016/j.cardfail.2007.03.011 Pollesello, 2004, ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction, Curr Opin Crit Care, 10, 436, 10.1097/01.ccx.0000145099.20822.19 Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 Caetano, 2014, Cardiorenal syndrome in acute heart failure: a vicious cycle?, Rev Port Cardiol, 33, 139, 10.1016/j.repc.2013.09.010 Hillege, 2006, Renal function as a predictor of outcome in a broad spectrum of patients with heart failure, Circulation, 113, 671, 10.1161/CIRCULATIONAHA.105.580506 Fonarow, 2005, Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis, JAMA, 293, 572, 10.1001/jama.293.5.572 Hillege, 2000, Renal function, neurohormonal activation, and survival in patients with chronic heart failure, Circulation, 102, 203, 10.1161/01.CIR.102.2.203 Parissis, 2007, Classical inotropes and new cardiac enhancers, Heart Fail Rev, 12, 149, 10.1007/s10741-007-9014-5 Damman, 2007, Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction, Eur J Heart Fail, 9, 872, 10.1016/j.ejheart.2007.05.010 Yilmaz, 2007, Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine, Cardiovasc Drugs Ther, 21, 431, 10.1007/s10557-007-6066-7 Yilmaz, 2009, Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure, Heart Vessels, 24, 16, 10.1007/s00380-008-1077-2 Ponikowski, 2016, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 Ronco, 2010, Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative, Eur Heart J, 31, 703, 10.1093/eurheartj/ehp507 Kellum, 2012, Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury, Kidney Int Suppl, 2, 1 Hou, 2013, Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction, Cardiovasc Ther, 31, 108, 10.1111/1755-5922.12001 House, 2011, Pharmacological management of cardiorenal syndromes, Int J Nephrol, 2011, 630809 Caetano, 2015, Continuous infusion or bolus injection of loop diuretics for patients admitted for severe acute heart failure: is one strategy better than the other?, Rev Port Cardiol, 34, 95, 10.1016/j.repc.2014.08.019 Follath, 2002, Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial, Lancet, 360, 196, 10.1016/S0140-6736(02)09455-2 Silva-Cardoso, 2009, Effectiveness and safety of levosimendan in clinical practice, Rev Port Cardiol, 28, 143 Zemljic, 2007, Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation, J Card Fail, 13, 417, 10.1016/j.cardfail.2007.03.005 Fedele, 2014, Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms, Eur J Heart Fail, 16, 281, 10.1002/ejhf.9 Bove, 2015, Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials, Heart Lung Vessels, 7, 35 Zhao-Zhuo, 2014, Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis, J Cardiovasc Pharmacol, 63, 107, 10.1097/FJC.0000000000000028 Sorsa, 2001, Binding of levosimendan, a calcium sensitizer, to cardiac troponin C, J Biol Chem, 276, 9337, 10.1074/jbc.M007484200 Toivonen, 2000, Electrophysiologic effects of a calcium sensitizer inotrope levosimendan administered intravenously in patients with normal cardiac function, J Cardiovasc Pharmacol, 35, 664, 10.1097/00005344-200004000-00021 Pataricza, 2003, Functional role of potassium channels in the vasodilating mechanism of levosimendan in porcine isolated coronary artery, Cardiovasc Drugs Ther, 17, 115, 10.1023/A:1025331617233 Paraskevaidis, 2005, Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: a novel mechanism of drug-induced improvement in contractile performance of the failing heart, Curr Med Chem Cardiovasc Hematol Agents, 3, 243, 10.2174/1568016054368232 Bergh, 2010, Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers, Eur J Heart Fail, 12, 404, 10.1093/eurjhf/hfq032 Almeida, 2016, Estimating glomerular filtration rate in acute coronary syndromes: different equations, different mortality risk prediction, Eur Heart J Acute Cardiovasc Care, 5, 223, 10.1177/2048872615576219 Cleland, 2006, Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE, Eur J Heart Fail, 8, 105, 10.1016/j.ejheart.2005.12.003 Mebazaa, 2007, Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial, JAMA, 297, 1883, 10.1001/jama.297.17.1883 Damman, 2007, Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application, Cardiovasc Drugs Ther, 21, 403, 10.1007/s10557-007-6070-y Pollesello, 2016, Levosimendan meta-analyses: is there a pattern in the effect on mortality?, Int J Cardiol, 209, 77, 10.1016/j.ijcard.2016.02.014